放射性标记脂蛋白以研究与管理疾病
本文综述放射性标记脂蛋白的方法及其在脂蛋白生物学研究和动脉粥样硬化、癌症、高胆固醇血症等疾病诊疗中的应用,作者通过广泛文献检索纳入200余篇同行评议研究并选取代表性案例进行高层次概述。
要点
- 脂蛋白是参与脂质转运与炎症的内源性纳米颗粒,可用于疾病诊断与治疗。
- 放射性标记是研究与治疗性利用脂蛋白的有力手段,涉及机制、诊断与治疗研究。
- 文献检索发现超过200篇同行评议论文涉及放射性标记脂蛋白,覆盖多种疾病。
核心结论
- 放射性标记对推进脂蛋白生物学理解及利用这些纳米材料诊疗疾病至关重要。
研究设计与样本
- 综述:对涉及放射性标记脂蛋白的全部同行评议研究进行广泛文献检索,并选取代表性案例进行高层次概述;检索到超过200篇同行评议论文。
主要发现
- 超过200篇同行评议论文涉及放射性标记脂蛋白,涵盖机制、诊断和治疗研究,跨越多种疾病。
关键数值与推荐
- 脂蛋白是参与脂质转运和炎症的内源性纳米颗粒;某些脂蛋白在动脉粥样硬化性心血管疾病患者中过表达;重组脂蛋白已广泛用于药物递送。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Lipoproteins are endogenous nanoparticles with essential roles in lipid transport and inflammation. Lipoproteins are also valuable in diagnosing and treating disease. For instance, certain lipoproteins are overexpressed in patients with atherosclerotic cardiovascular disease, and reconstituted lipoproteins have been extensively used for drug delivery. Radiolabeling has proven an especially powerful approach for studying and therapeutically exploiting lipoproteins. This review details how radiochemistry and nuclear imaging can facilitate the study of lipoproteins in health and disease. Among other topics, we discuss approaches for radiolabeling lipoproteins and detail how these have helped advance our understanding of lipoprotein biology and the diagnosis and treatment of diseases, including atherosclerosis, cancer, and hypercholesteremia. METHODS: We performed an extensive literature search on all peer-reviewed studies involving radiolabeled lipoproteins and selected representative examples to provide a high-level overview of the most important discoveries and technological advancements. RESULTS: More than 200 peer-reviewed papers involved radiolabeled lipoproteins, spanning mechanistic, diagnostic, and therapeutic studies across a wide range of diseases. CONCLUSION: Radiolabeling has been critical in advancing our understanding of lipoprotein biology and leveraging these nanomaterials for diagnosing and treating disease.
引用
- Pérez-Medina C, Fisher EA, Fayad ZA, et al. Radiolabeling lipoproteins to study and manage disease. Eur J Nucl Med Mol Imaging. 2025. PMID: 40293448. doi:10.1007/s00259-025-07281-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。